Fluhexette Tablet contains a combination of Trifluoperazine (2.5 mg) and Trihexyphenidyl (1 mg), formulated to manage symptoms associated with schizophrenia and other psychotic disorders. Trifluoperazine is a typical antipsychotic that works by blocking dopamine receptors in the brain, helping to reduce hallucinations, delusions, and agitation. Trihexyphenidyl is an anticholinergic agent used to counteract extrapyramidal side effects such as tremors, rigidity, and muscle stiffness, which are common with antipsychotic therapy. This combination enhances patient compliance by minimizing motor side effects while effectively controlling psychotic symptoms. Fluhexette is indicated for the treatment of schizophrenia, psychotic disorders, and as an adjunct in managing drug-induced extrapyramidal symptoms. It should be used under medical supervision, with dosage tailored to individual patient needs. Common side effects may include dry mouth, dizziness, blurred vision, constipation, and sedation. Caution is advised in patients with a history of cardiac disorders, glaucoma, or urinary retention. Regular monitoring by a healthcare professional is essential to ensure efficacy and safety. Fluhexette Tablet should not be discontinued abruptly to avoid withdrawal symptoms or relapse of psychosis.